Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Synthetic Biology

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...

Bacterial Transformation

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...

Bacterial Transformation

Bacterial Transformation

Biological Methods for Microbial Control

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...

Bioreactor Controls-III

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sustainable co-production of 1,3-PDO, ethanol and H<sub>2</sub> from glycerol via dark fermentation by <i>Citrobacter telavivensis</i> T1.2D-1 isolated from the deep subsurface.

Frontiers in bioengineering and biotechnology·2026

Same author

Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms: a novel strategy against infections.

NPJ biofilms and microbiomes·2025

Same author

The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes.

Gut microbes·2025

Same author

Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance.

eLife·2024

Same author

Engineering Mycoplasma pneumoniae to bypass the association with Guillain-Barré syndrome.

Microbes and infection·2024

Same author

Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration.

Analytical chemistry·2024

Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026

Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026

Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026

Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026

Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026

Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 10, 2026

Bioluminescent Bacterial Imaging In Vivo

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

Engineered bacteria as therapeutic agents.

Carlos Piñero-Lambea¹, David Ruano-Gallego¹, Luis Ángel Fernández¹

¹Department of Microbial Biotechnology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Campus UAM Cantoblanco, 28049 Madrid, Spain.

Current Opinion in Biotechnology

|June 13, 2015

Summary

This summary is machine-generated.

Engineered bacteria can be developed into smart therapeutics to treat diseases like cancer and autoimmune disorders. Synthetic biology advances enable reprogramming bacteria for therapeutic uses, including novel biocontainment strategies.

More Related Videos

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

Related Experiment Videos

Last Updated: Apr 10, 2026

Bioluminescent Bacterial Imaging In Vivo

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

Area of Science:

Microbiology
Synthetic Biology
Biotechnology

Background:

Most bacteria in the human body are non-pathogenic.
Bacteria can be engineered into 'smart' living therapeutics.
Potential applications span various human pathologies and infections.

Purpose of the Study:

To review recent developments in engineering bacteria for therapeutic purposes.
To highlight the use of synthetic biology in reprogramming bacteria.
To discuss advancements in biocontainment for engineered bacteria.

Main Methods:

Review of current literature on engineered bacteria as therapeutics.
Analysis of synthetic biology tools for bacterial reprogramming.
Examination of biocontainment strategies for safety.

Main Results:

Engineered bacteria show promise for treating inflammatory bowel diseases, autoimmune disorders, cancer, and metabolic diseases.
Reprogrammed bacteria can combat bacterial and viral infections.
Synthetic biology offers advanced methods for precise bacterial engineering.

Conclusions:

Engineered bacteria represent a novel frontier in 'smart' living therapeutics.
Synthetic biology is key to unlocking the full therapeutic potential of bacteria.
Effective biocontainment is crucial for the safe clinical application of engineered bacterial therapeutics.